...
首页> 外文期刊>Biochemical Pharmacology >Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner
【24h】

Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner

机译:卡维地洛以β-肾上腺素受体非依赖性方式阻断克隆的心脏Kv1.5通道

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Carvedilol, a non-selective β-adrenergic blocker, is widely used for the treatment of angina pectoris and hypertension. We examined the action of carvedilol on cloned Kv1.5 expressed in CHO cells, using the whole-cell patch clamp technique. Carvedilol reduced the peak amplitude of Kv1.5 and accelerated the inactivation rate in a concentration-dependent manner with an IC 50 of 2.56 μM. Using a first-order kinetics analysis, we calculated k +1 = 19.68 μM -1 s -1 for the association rate constant, and k -1 = 44.89 s -1 for the dissociation rate constant. The apparent K D (k -1/k +1) was 2.28 μM, which is similar to the IC 50 value. Other β-adrenergic blockers (alprenolol, oxprenolol and carteolol) had little or no effect on Kv1.5 currents. Carvedilol slowed the deactivation time course, resulting in a tail crossover phenomenon. Carvedilol-induced block was voltage-dependent in the voltage range for channel activation, but voltage-independent in the voltage range for full activation. The voltage dependences for both steady-state activation and inactivation were unchanged by carvedilol. Carvedilol affected Kv1.5 in a use-dependent manner. When stimulation frequencies were increased to quantify a use-dependent block, however, the block by carvedilol was slightly increased with IC 50 values of 2.56 μM at 0.1 Hz, 2.38 μM at 1 Hz and 2.03 μM at 2 Hz. Carvedilol also slowed the time course of recovery from inactivation of Kv1.5. These results indicate that carvedilol blocks Kv1.5 in a reversible, concentration-, voltage-, time-, and use-dependent manner, but only at concentrations slightly higher than therapeutic plasma concentrations in humans. These effects are probably relevant to an understanding of the ionic mechanism underlying the antiarrhythmic property of carvedilol.
机译:卡维地洛是一种非选择性的β-肾上腺素能阻滞剂,被广泛用于治疗心绞痛和高血压。我们使用全细胞膜片钳技术检查了卡维地洛对在CHO细胞中表达的克隆Kv1.5的作用。卡维地洛以浓度依赖的方式降低了Kv1.5的峰幅度并加快了灭活速率,IC 50为2.56μM。使用一级动力学分析,我们计算出k +1 = 19.68μM-1 s -1的缔合速率常数,k -1 = 44.89 s -1的解离速率常数。表观K D(k -1 / k +1)为2.28μM,类似于IC 50值。其他β-肾上腺素能阻滞剂(alprenolol,oxprenolol和Carteolol)对Kv1.5电流几乎没有影响。卡维地洛减慢了失活时间,导致了尾巴交叉现象。卡维地洛诱导的阻滞在通道激活的电压范围内与电压有关,但在完全激活的电压范围内与电压无关。卡维地洛没有改变稳态激活和失活的电压依赖性。卡维地洛以依赖使用的方式影响Kv1.5。但是,当增加刺激频率以量化使用相关的阻滞剂时,卡维地洛的阻滞剂会稍微增加,IC 50值在0.1 Hz时为2.56μM,在1 Hz时为2.38μM,在2 Hz时为2.03μM。卡维地洛还减缓了Kv1.5灭活的恢复时间。这些结果表明卡维地洛以可逆,浓度,电压,时间和使用依赖的方式阻断Kv1.5,但仅在浓度略高于人体的治疗性血浆浓度时才能阻断。这些作用可能与对卡维地洛抗心律不齐特性背后的离子机制的了解有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号